Skip to search
Skip to main content
Back to Search
Start Over
Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 205 Study
Authors :
Cohen, J. B. Engert, A. Ansell, S. M. Younes, A. Trneny, M. Savage, K. J. Ramchandren, R. Collins, G. P. Fanale, M. A. Armand, P. Zinzani, P. L. de Boer, J. P. Shipp, M. A. Santoro, A. Timmerman, J. M. Sacchi, M. Sy, O. Kuruvilla, J. Cohen, J. B. Engert, A. Ansell, S. M. Younes, A. Trneny, M. Savage, K. J. Ramchandren, R. Collins, G. P. Fanale, M. A. Armand, P. Zinzani, P. L. de Boer, J. P. Shipp, M. A. Santoro, A. Timmerman, J. M. Sacchi, M. Sy, O. Kuruvilla, J.
Publication Year :
2018
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1201319805
Document Type :
Electronic Resource